PFE News 27.70 10/17/2014 05:32:56 Pfizer Inc (PFE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 27.70 $PFE

Most active New York Stock Exchange-traded stocks
AP - Thu Oct 16, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
GE: 24.25 (-0.03), F: 13.98 (+0.36), RF: 9.06 (-0.04), AMD: 2.64 (+0.03), PFE: 27.70 (-0.49), BAC: 16.08 (+0.32), TWTR: 48.23 (-1.76), RAD: 4.61 (-0.06)

Final Glance: Pharmaceuticals companies
AP - Thu Oct 16, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 96.78 (-1.43), BAX: 68.18 (-0.16), PFE: 27.70 (-0.49), BMY: 49.22 (+0.26)

FDA panel votes to keep boxed warning on Chantix
AP - Thu Oct 16, 3:10PM CDT
WASHINGTON (AP) — Federal health advisers say a bold-letter warning about suicide risks with Pfizer's Chantix should remain on the anti-smoking drug until it can reevaluated based on new, rigorous study information.
PFE: 27.70 (-0.49)

Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals
at Investor's Business Daily - Thu Oct 16, 2:07PM CDT
Medical products giant Baxter International (BAX) beat Q3 earnings estimates and lifted its 2014 organic sales growth guidance Thursday, though it lowered its EPS outlook due to a divestiture. Its stock initially dropped but by early afternoon was up...
BIIB: 302.74 (-2.95), BAX: 68.18 (-0.16), PFE: 27.70 (-0.49)

Can health-care stock funds stay on top?
By STAN CHOE - AP - Thu Oct 16, 1:54PM CDT
NEW YORK (AP) — When swings in the stock market cause anxiety to spike, like it is now, many investors aim to get healthy.
JNJ: 96.78 (-1.43), MRK: 53.43 (-1.30), PFE: 27.70 (-0.49)

Midday Glance: Pharmaceuticals companies
AP - Thu Oct 16, 12:21PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 96.78 (-1.43), BAX: 68.18 (-0.16), PFE: 27.70 (-0.49), BMY: 49.22 (+0.26)

Early Glance: Pharmaceuticals companies
AP - Thu Oct 16, 10:35AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 96.78 (-1.43), BAX: 68.18 (-0.16), PFE: 27.70 (-0.49), BMY: 49.22 (+0.26)

Shire Can Thrive Without AbbVie, Say Analysts
at Investor's Business Daily - Thu Oct 16, 10:19AM CDT
Specialty drugmaker Shire faced a future as a stand-alone company Thursday after AbbVie directors late Wednesday voted against a planned acquisition. Investors and analysts seemed optimistic, though, as Shire (SHPG) stock was up 3% in early trading...
AGN: 178.00 (+0.41), PFE: 27.70 (-0.49), SHPG: 178.46 (+7.97), ABBV: 52.90 (-1.73)

3 Small-Cap Biotech Stocks to Buy if the Market Crashes
Todd Campbell, The Motley Fool - Motley Fool - Wed Oct 15, 1:38PM CDT
The Russell 2000  small-cap stock index is the most widely used proxy for small-cap stocks and the exchange traded fund that tracks that index  has tumbled 11.6% this year. That's a frightening drop, but it's been proven time and time again that...
JNJ: 96.78 (-1.43), INSY: 38.38 (+1.10), PTLA: 25.90 (+0.08), PFE: 27.70 (-0.49), MRK: 53.43 (-1.30), OPHT: 40.51 (-0.24), IWM: 107.80 (+1.20), BMY: 49.22 (+0.26), REGN: 340.71 (+5.96)

Shire Falls, AbbVie Questioned On Buyout Backtrack
at Investor's Business Daily - Wed Oct 15, 12:11PM CDT
Shares of specialty drugmaker Shire plummeted 23% on the stock market today after word got out late Tuesday that big pharma AbbVie is reconsidering its $55 billion buyout of the company. Shire (SHPG) confirmed the reports Wednesday morning with a...
ABT: 39.99 (-0.02), AZN: 67.56 (-0.85), PFE: 27.70 (-0.49), SHPG: 178.46 (+7.97), SLXP: 137.38 (+4.96), MYL: 48.77 (+1.39), ABBV: 52.90 (-1.73)

Pfizer (PFE) Breaks Through Support at $28.31
Comtex SmarTrend(R) - Wed Oct 15, 10:40AM CDT
Shares of Pfizer (NYSE FE) opened today below their pivot of $28.55 and have already reached the first level of support at $28.31. Should the shares continue to fall, the support pivots of $28.15 and $27.75 will be of interest.
PFE: 27.70 (-0.49)

AbbVie Backs Away From Shire Takeover After Tax Changes
at The Street - Wed Oct 15, 9:27AM CDT
The Dublin target insists the deal should go ahead and notes that it's in line for a $1.635 billion breakup fee if it collapses.
MDT: 61.81 (-0.44), SHPG: 178.46 (+7.97), PFE: 27.70 (-0.49), COV: 85.50 (-0.36), ABBV: 52.90 (-1.73)

Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg
Brian Orelli, The Motley Fool - Motley Fool - Wed Oct 15, 7:45AM CDT
If one drug is good, two drugs must be better. That seems to be what Johnson & Johnson and Bristol-Myers Squibb are thinking with the clinical trial collaboration agreement they entered to test Johnson & Johnson's Imbruvica with...
JNJ: 96.78 (-1.43), PCYC: 109.14 (+1.11), PFE: 27.70 (-0.49), MRK: 53.43 (-1.30), BMY: 49.22 (+0.26), NVS: 85.02 (-1.20)

FDA Sends Mixed Message On Safety of Pfizer inc.'s Chantix
Brian Orelli, The Motley Fool - Motley Fool - Wed Oct 15, 7:35AM CDT
Sales of Pfizer 's Chantix were knocked down a few years ago when the Food and Drug Administration slapped a black box warning on the smoking cessation drug after reports of patients experiencing neuropsychiatric events, including thoughts of...
PFE: 27.70 (-0.49), GSK: 42.88 (-0.25)

European Stocks Fall on Continued Worries Over Eurozone Economy
at The Street - Wed Oct 15, 4:58AM CDT
European stocks fall on Wednesday, failing to take their cue from a largely positive day in Asia as investors continue to worry about the outlook for the eurozone economy.
SHPG: 178.46 (+7.97), QCOM: 71.14 (-0.06), PFE: 27.70 (-0.49), MCHP: 39.19 (+1.46), AZN: 67.56 (-0.85), ABBV: 52.90 (-1.73)

Global Partial Seizure Clinical Trials Review, H2, 2014
M2 - Wed Oct 15, 3:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8gwn27/partial_seizure) has announced the addition of the "Partial Seizure Global Clinical Trials Review, H2, 2014" report to their offering. Partial Seizure Global Clinical Trials Review, H2, 2014 provides data on the Partial Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Partial Seizure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Partial Seizure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Partial Seizure Therapeutics Clinical Trials - UCB S.A. - Pfizer Inc. - Eisai Co., Ltd. - Novartis AG - Johnson & Johnson - GlaxoSmithKline plc - Bial - Portela & Ca, S.A. - SK Holdings Co., Ltd. - Upsher-Smith Laboratories, Inc. - Abbott Laboratories - National Institute of Neurological Disorders and Stroke - Emory University - Oregon Health & Science University - Kyoto University - National Center for Complementary and Alternative Medicine - Hadassah Medical Organization - University of Pennsylvania - Lawson Health Research Institute - Massachusetts General Hospital - University of California, Davis For more information visit http://www.researchandmarkets.com/research/8g...al_seizure
JNJ: 96.78 (-1.43), ABT: 39.99 (-0.02), PFE: 27.70 (-0.49), GSK: 42.88 (-0.25), NVS: 85.02 (-1.20)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Holiday Grease Advice Shows Utility Work Up Close Today

Updated Category News Views 117

Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 101

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
Xailient Tops NIST for Real-World AI Face Recognition

Updated Category News Views 58

In a world where bigger ain't always better, Xailient's latest triumph at NIST's face recognition test has set them apart. On November 17, 2026, the U.S. National Institute of Standards and Technology (NIST) crowned Xailient as the leader in face recognition accuracy for on-device AI, leaving 105 others in the dust. This ain't your run-of-the-mill achievement—it shows...

Continue Reading
SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 113

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 75

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Yeahka Bids to Lead AI Shopping Evolution

Updated Category News Views 43

AI Shopping: A New Frontier or A Sisyphean Task? The evolution of AI from sassy recommendation tools to transaction-executing agents is shaking up the retail sector. Enter Stage Left: Yeahka Limited (9923.HK), a payment tech outfit that's wading into this murky digital swamp. With YeahPay and Fushi Tech, they're trying to hammer out a blueprint for AI-friendly commerce...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 124

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 141

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading
Medical School Rejections Carry a Steep Price Tag Too

Updated Category News Views 107

A rejection letter can turn into a remarkably expensive piece of paper. BeMo Academic Consulting's new Medical School Admissions Trends Report argues that the damage from missing medical-school admission goes far beyond bruised confidence: applicants can spend thousands chasing another cycle, lose time entering practice, and, if they never get in, forgo what the report...

Continue Reading
Suntory Flowers Tests NASCAR as a Garden Retail Engine

Updated Category News Views 73

Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Coop Pank Reveals Q3 2025 Financial Results During Webinar

Updated Category News Views 161

Insights from Coop Pank's Recent Investor Webinar Coop Pank recently held an engaging investor webinar to discuss their unaudited financial results for the third quarter of 2025. During this informative session, Arko Kurtmann, the Chairman of the Management Board, and Paavo Truu, the Chief Financial Officer, elaborated on the bank's performance, highlighting significant...

Continue Reading
inTEST EMS Expands Market Reach Through New Distributor

Updated Category News Views 261

inTEST EMS Partners with General Bussan Co., Ltd. inTEST Electronic Test, part of inTEST Corporation (NYSE American: INTT), has announced a significant strategic partnership with General Bussan Co., Ltd. This collaboration is aimed at enhancing the distribution of inTEST EMS Products' high-quality manipulators, interface solutions, and docking systems designed...

Continue Reading
Gordon Brothers List Union Electric Steel Plant for Sale

Updated Category News Views 230

Gordon Brothers List Union Electric Steel Plant for Sale In the recent announcement, Gordon Brothers, renowned experts in asset management, are presenting a noteworthy opportunity for interested buyers. The entire roll manufacturing facility of Union Electric Steel Limited is now available for private sale, conducted by joint administrators. This facility is located in...

Continue Reading
AHLA Foundation's Summit Empowers Survivors and Experts

Updated Category News Views 157

Uniting Voices Against Human Trafficking The AHLA Foundation recently brought together a dynamic group of survivors, industry experts, and leaders at the No Room for Trafficking (NRFT) Summit. This significant event emphasized the importance of collaboration in the fight against human trafficking, focusing on education and the distribution of vital resources aimed at...

Continue Reading
Trump Media's Stock Reactions Amid Market Fluctuations Analysis

Updated Category News Views 158

Trump Media's Stock Takes a Hit Amid Insider Selling Concerns The shares of Trump Media have been quite turbulent lately, especially following reports that insiders within the company were given the green light to sell their holdings. This news is closely linked to former President Donald Trump, who has a significant stake in the company. Snapshot of Current Stock...

Continue Reading